Psoriasis
Conditions
Interventions
Experimental group:Jianpi Jiedu pill oral
Sponsors
Xinjiang Institute of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients with spleen deficiency and dampness excess syndrome of psoriasis vulgaris were definitely diagnosed; 2. Aged 18 to 70 years; 3. The course of disease was 0 to 20 years; 4. Informed consent, voluntary treatment, observation and examination.
Exclusion criteria
Exclusion criteria: 1. Arthritis type, pustular type, erythroderma type psoriasis; 2. Systematic treatment within 3 months, including large-area topical use of powerful cortical sterols or immunosuppressants; 3. Patients with serious primary diseases or psychosis such as cardio cerebrovascular, liver and kidney and hematopoietic system; 4. Pregnant, prepare for pregnancy or lactating women; 5. Those who fail to use drugs according to regulations, cannot judge the curative effect, or incomplete data affect the judgment of curative effect or safety.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Psoriasis Area and Severity Index, PASI;Recurrence rate of psoriasis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to relapse;Onset time;Rebound rate;Dosage of Western medicine for external use;visual analogue scale, VAS;body surface area, BSA;dermatology life quality index, DLQI;Self-Rating Anxiety Scale, SAS;Self-rating depression scale, SDS; | — |
Countries
China
Contacts
Public ContactLiu Hongxia
Outcome results
None listed